CVE-2016-1913: Multiple cross-site scripting (XSS) vulnerabilities in the Redhen module 7.x-1.x before 7.x-1.11 for Drupal al
CVE-2016-1913 is a medium-severity flaw (CVSS 5.4) affecting redhen. Below: why it ranks where it does, which versions are affected, what to do, and the exact commands.
Multiple cross-site scripting (XSS) vulnerabilities in the Redhen module 7.x-1.x before 7.x-1.11 for Drupal allow remote authenticated users with certain access to inject arbitrary web script or HTML via unspecified vectors, related to (1) individual contacts, (2) notes, or (3) engagement scores.
Why this priority
- No elevated risk signals yet
No fix is published yet: follow the downgrade or mitigation steps.
Risk facts
| CVSS score | 5.4 (Medium) |
| Attack vector | Network (remote) |
| Attack complexity | Low |
| Privileges needed | Low |
| User interaction | Required |
| EPSS exploit chance | 0.6% (top 51%) |
| CISA exploited list | No |
| Weakness | CWE-79 |
| Published | 2016-01-15 |
| Last modified | 2026-06-17 |
Last updated 2026-06-17 · Sources: CVE Program, NVD, CISA KEV, EPSS and vendor advisories · How we score
Am I affected?
Timeline
- Published CVE record published
- Updated Record last modified
Scores and fixes here are computed automatically from those and other public sources. Confirm with the vendor advisory before changing production systems.
Quick answers
How do I fix CVE-2016-1913?
redhen: downgrade or apply the listed mitigation. Exact commands for each OS are on this page.
Is CVE-2016-1913 being exploited?
CVE-2016-1913 is not on the CISA Known Exploited Vulnerabilities list at the time of the last update. Check again, as this can change.
What does CVE-2016-1913 affect?
CVE-2016-1913 affects redhen. Severity is medium (CVSS 5.4). Multiple cross-site scripting (XSS) vulnerabilities in the Redhen module 7.x-1.x before 7.x-1.11 for Drupal allow remote authenticated users with certain access to inject arbitrary web script or HTML via unspecified vectors, related to (1)
How urgent is CVE-2016-1913?
Priority 31/100. No elevated risk signals yet.